| |
|
|
|
Fulgent Genetics Inc.  
|
|
11.9 1.43 (0.14%) |
08-19 16:00 |
|
Open: |
10.69 |
Pre close: |
10.47 |
Target:
|
14.53
|
|
High: |
11.9 |
Low: |
10.69 |
Resistance:
|
12.44
14.53
|
|
Volume: |
95,237 |
Market Cap: |
245M |
Support:
|
8.43
5.95
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
10.81
 |
MACD |
MACD(12,26):
|
1.27 |
|
MA(20): |
8.77 |
Signal(12,26,9): |
1.06 |
|
MA(100): |
6.65 |
Stochastic Oscillator |
%K(14,3):
|
75.08 |
|
MA(250): |
5.04 |
%D(3): |
70.29  |
|
Average Volume(K) |
3-Month: |
3561
|
52-Week |
High:
|
12.44 |
|
10-Days: |
14143 |
Low: |
3.02 |
|
RSI |
RSI(14):
|
71.57 |
Change(%): |
171.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.230 |
Return on Equity (ttm) |
-8.1 |
Shares Out. (M) |
18.32 |
|
EPS Est. Current Year |
0.140 |
Return on Assets (ttm) |
-3.8 |
Shares Float (M) |
7.81 |
|
EPS Est. Next Year |
0.320 |
PEG Ratio |
7.80 |
% Held by Insiders |
68.90 |
|
EPS Est. Next Quarter |
0.070 |
Qtrly Rev. Growth |
56.0 |
% Held by Institutions |
6.74 |
|
Forward EPS |
0.070 |
Gross Profit (p.s.) |
0.581 |
Shares Short (K) |
10 |
|
Book Value (p.s.) |
2.780 |
EBITDA (p.s.) |
-0.069 |
P/E |
-51.74 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
4.28 |
|
Profit Margin |
-16.84 |
Operating Cash Flow
(M) |
2.40 |
P/S |
157976800.00 |
|
Operating Margin |
-13.56 |
Levered Free Cash Flow
(M) |
0.02 |
P/CF |
90.84 |
|
|
|
|
|
|
